Itraconazole or Amphotericin B for Talaromycosis. - Author Reply
Giovane et al inquired whether the treatment effects differed on the basis of disease severity or preexisting medical conditions. First, we caution that criteria for severe disease have not been defined for talaromycosis. Second, international guidelines recommending itraconazole for mild to moderat...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Massachusetts Medical Society
2017
|